about
Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communicationFragile X: translation in actionAdvances in autism genetics: on the threshold of a new neurobiologyCorrection of fragile X syndrome in mice.Prospects for Improving Brain Function in Individuals with Down SyndromeFragile X syndrome: loss of local mRNA regulation alters synaptic development and functionPathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses.The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome)Emerging pharmacotherapies for neurodevelopmental disordersGroup 1 mGluR-dependent synaptic long-term depression: mechanisms and implications for circuitry and diseaseEnhanced polyubiquitination of Shank3 and NMDA receptor in a mouse model of autismTherapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderFMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autismAdvances in the treatment of fragile X syndromeFragile x syndromeMultiple rare variants in the etiology of autism spectrum disordersTemporal requirements of the fragile X mental retardation protein in the regulation of synaptic structureA pilot open label, single dose trial of fenobam in adults with fragile X syndrome.Norbin is an endogenous regulator of metabotropic glutamate receptor 5 signalingThe role of neuronal complexes in human X-linked brain diseasesTranscriptional Reactivation of the FMR1 Gene. A Possible Approach to the Treatment of the Fragile X SyndromeWhere Environment Meets Cognition: A Focus on Two Developmental Intellectual Disability DisordersA new look at an old drug: neuroprotective effects and therapeutic potentials of lithium saltsSynaptic Plasticity, a Prominent Contributor to the Anxiety in Fragile X SyndromeClinical and Neurobiological Relevance of Current Animal Models of Autism Spectrum Disorders.The PI3K signaling pathway as a pharmacological target in Autism related disorders and Schizophrenia.SYNGAP1: Mind the GapProteostasis and RNA Binding Proteins in Synaptic Plasticity and in the Pathogenesis of Neuropsychiatric DisordersStriatal Circuits as a Common Node for Autism PathophysiologySingle-Nucleotide Mutations in FMR1 Reveal Novel Functions and Regulatory Mechanisms of the Fragile X Syndrome Protein FMRPRNA-binding proteins, neural development and the addictionsAdvances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum DisorderDysregulation and restoration of translational homeostasis in fragile X syndromeDysregulation of Mammalian Target of Rapamycin Signaling in Mouse Models of AutismThe role of cerebellar circuitry alterations in the pathophysiology of autism spectrum disordersAltered Neuronal and Circuit Excitability in Fragile X Syndrome.Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum DisordersFragile X spectrum disordersThe function of metabotropic glutamate receptors in thalamus and cortexEmerging pharmacologic treatment options for fragile X syndrome
P2860
Q21198697-AC141BC6-2189-462D-93CF-4886F3D90760Q22250986-5FADD956-3058-49EC-81FC-524D334CA125Q22251023-3F810364-F69F-41A7-8B04-052C114F8F30Q22251255-2988EBC1-DAB1-4A42-BAF6-4C515E7B8EE6Q22252566-D91E9A08-05A0-4867-94F3-65CD340F71ECQ24608468-6F8FE4B4-0863-40D6-9CAF-4528F936FEBEQ24610600-7AE244DC-1F99-4B8C-BDF5-7C2A16848DD0Q24612792-B9D30838-7146-436B-B1CC-FD3705FE17E2Q24619170-2FCF5258-C1D4-4D88-BA8E-CF886469BBCDQ24620534-7AC8BB41-6866-4758-AF35-6039F202F5C1Q24620573-C53E0DBF-CDAA-456E-8447-93BF3DD196C1Q24626017-BB521E5B-6114-42B3-8102-61955D1C4A8CQ24631425-B6A2CF0D-5087-4A36-B46B-90CF16AF38F9Q24632814-50433608-7D49-47C4-9243-96692B7491ECQ24633000-5D5D55E0-9B66-4572-9B78-A11BD01DCFBCQ24635522-068E2FE3-8B10-4E14-9A38-C1F7C159D317Q24645505-32B9538C-AC22-48B7-AEFF-FC3C13E1B351Q24654933-BF5107E4-414C-48F2-93BA-D22AB95D810AQ24655546-F399BFAD-DA83-488D-9251-3E44C599A7C5Q24680472-150158C8-3C63-4A58-871A-BC28E7DDA582Q26739927-5B1C6CFC-6046-4224-92C9-0F6DF4A1B9BFQ26740071-E3CCA676-481C-4D14-BF19-9FF530EBE422Q26741164-5580A99D-B71C-418D-92AF-B4E9B9C8EE3AQ26745117-3F848824-0CEA-4C8B-84A5-FA20F6C6D25EQ26748761-DD67D126-3D01-4BE9-B16C-0994A6C8D297Q26766054-2332E7CB-9EB0-4D53-B4A9-5B9A5701CCABQ26766506-6FBA19B5-D768-4BE4-AE5C-0B7B95283D85Q26767347-9B64918B-D6F6-4CD5-9920-EAD3CAAE54D4Q26768226-1E768917-CDCB-4BEA-9784-2B3A9BD6F062Q26773167-EC4DE8EC-5F29-41FB-A955-B030C8255A01Q26773909-00DD83F8-EABB-47E5-A9CE-1BA35D63670BQ26781265-D78B4246-FBEB-496A-903D-1D395AB3C8CBQ26782616-BA5EC7DA-6A17-478D-A63F-9ABC513DE1F9Q26782948-47E9EFBA-3309-4058-816A-DE2B0C8C9424Q26783008-4FF935C9-BFF4-42C9-A072-86A351560AC6Q26796317-D14A6724-B10F-443B-98FE-FB33C03FEB7FQ26796321-142D5EF4-88E6-4CD6-92A2-3C6AEA6B92AAQ26824376-61BFDC03-AE6D-4DF9-996E-95C1DAF3342CQ26828004-B2FE5955-29E1-4D9A-B636-D700A72A9589Q26829152-7E93A01D-82E7-4F75-AB12-8A2540C8DABF
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The mGluR theory of fragile X mental retardation
@ast
The mGluR theory of fragile X mental retardation
@en
type
label
The mGluR theory of fragile X mental retardation
@ast
The mGluR theory of fragile X mental retardation
@en
prefLabel
The mGluR theory of fragile X mental retardation
@ast
The mGluR theory of fragile X mental retardation
@en
P2093
P3181
P1476
The mGluR theory of fragile X mental retardation
@en
P2093
P3181
P356
10.1016/J.TINS.2004.04.009
P407
P577
2004-07-01T00:00:00Z